ARCHIVES

McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.

This article is from The Cancer Letter archive.

Vol. 26 No. 22 | June 2, 2000

Download PDF Visit The Full Archive

Related Articles

DCT’s Experimental Therapeutic Program Outlined to Board

May 2, 1975

In Brief: ACOS Analysis Finds Conclusive Shift To Modified Radical, Earlier Detection, Treatment For Blacks

September 4, 1981

DES Exposure Studies Below Payline; NCI Considers Contracts

March 6, 1992

Dipersio Is Chief Of Oncology At Washington University.

July 14, 2000

Cancer Control RFA Announcements

March 9, 1979

NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions

October 16, 2009